Voyageur Net Income From Continuing Ops from 2010 to 2026
| VM Stock | CAD 0.18 0.01 5.88% |
Net Loss | First Reported 2016-11-30 | Previous Quarter -817.6 K | Current Value -544.3 K | Quarterly Volatility 192.2 K |
Check Voyageur Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Voyageur Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 757.3 K, Other Operating Expenses of 779.8 K or Total Operating Expenses of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.13. Voyageur financial statements analysis is a perfect complement when working with Voyageur Pharmaceuticals Valuation or Volatility modules.
Voyageur | Net Income From Continuing Ops |
Latest Voyageur Pharmaceuticals' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Voyageur Pharmaceuticals over the last few years. It is Voyageur Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Voyageur Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Voyageur Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (939,417) | |
| Coefficient Of Variation | (73.85) | |
| Mean Deviation | 634,501 | |
| Median | (670,752) | |
| Standard Deviation | 693,782 | |
| Sample Variance | 481.3B | |
| Range | 2M | |
| R-Value | (0.88) | |
| Mean Square Error | 119.4B | |
| R-Squared | 0.77 | |
| Slope | (120,363) | |
| Total Sum of Squares | 7.7T |
Voyageur Net Income From Continuing Ops History
About Voyageur Pharmaceuticals Financial Statements
Voyageur Pharmaceuticals investors use historical fundamental indicators, such as Voyageur Pharmaceuticals' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Voyageur Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -1.5 M | -1.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.